Lovely professional university CASE STUDY OF DATA MINING Summitted by Jatin Sharma Roll no -32. Reg. no 10802192 A case study in Data Warehousing and Data mining Using the SAS System. Data Warehouses The drop in price of data storage has given companies willing to make the investment a tremendous resource:
Premium Data mining Data warehouse Data management
Merge che rs & Ac AstraZ eneca Sapom p Wohnb au quisiti J&J Ardea Bioscie n ons of Abbott ces the Top 20 in th Eli Lilly Astra T ech Bayer Synthe s Novex el uest Pirama Acclare l nt Couga Solvay r Mento OMRIX Conor Medsy s Talecri s ICOS TheraS Abbott Invern es Medtec s h ALZA BASF Bayer Foods IVAX SS AG a ca Centoc or ix 20 nco Medise Anima 60 0 20 40 Pharm a Delta P harma g Ops h BU STEAG Vaccin e Man. Plant FH Fau lding BMS O US&Ca
Premium Pharmaceutical industry Mergers and acquisitions Novartis
Porter’s Five Forces Forces Grade Note Segment Rivalry Strong The current market is divided between a few powerful competitors that can relatively easily attract customers from one another as the switching costs are low and practical absence of product differentiation contributes to the easy loss of market share. Threat of Mobility Weak While the new entrants only need a relatively simple GUI and a supplier in order to enter the market‚ the federal and local regulations will require significant
Premium Customer service Retailing Sales
the company was $2‚311.7 million during FY2012‚ an increase of 11.6% over FY2011. The net profit was $1‚275.8 million in FY2012‚ an increase of 8% over FY2010 (Datamonitor 2012). In April 2012‚ Express Scripts completed acquisition of Medco Health Solutions (Medco)‚ for $29.1 billion. With medical costs outpacing the rate of inflation‚ PBMs work to keep medications affordable (Datamonitor 2012). Representative of most PBMs‚ Express Scripts profits from business in the following four areas:
Premium Pharmacology Health care Health insurance
MGMT 446: Strategic Management (Spring 2013) Case Analyses—Schedule‚ Format‚ and Required Items Per the syllabus‚ p. 4-5‚ you must submit three (3) written Case Analyses. Each of these case analyses (papers) is worth a maximum of 100 points. Below the cases are grouped into UNIT 1‚ UNIT 2‚ and UNIT 3 case options. You must complete one (1) case paper from EACH of these Units (3 case papers total). No late cases will be accepted for a grade. NOTE: The first case appearing on the Course
Premium Retailing Case study Scientific method
October 9‚ 2011‚ from The New York Times: http://www.nytimes.com/2007/10/09/business/09film.html?ref=business Kamp‚ J Kamp‚ J. (2011‚ September 20). Odds of Express Scripts-Medco Merger Are 80%‚ Analyst Says. Retrieved September 30‚ 2011‚ from Wall Street Journal: http://blogs.wsj.com/deals/2011/09/21/odds-of-express-scripts-medco-merger-are-80-analyst-says/ Kamp‚ J Major‚ M. (2006). Fancy Footwork. Progressive Grocer. Manta. (n.d.). 83‚040 Drug Stores and Proprietary Stores in the U.S. Retrieved September
Premium Rite Aid Pharmacy Pharmacology
Google’s organisational structure 1.1. 1 Definition Organizational structure refers to the different hierarchies or levels in a company. An organizational structure appears as a series of boxes‚ vertical and horizontal lines. The boxes represent various titles within the organization‚ and the vertical lines represent to whom that position reports. Horizontal lines show which employees are on the same level. The appearance of an organization structure is usually pyramidal because there are fewer
Premium Organization Organizational studies and human resource management Apple Inc.
generally characterized by spasm of the arterioles in an individual’s extremities; fingers‚ hands‚ feet and toes (Frazier: 490) (Merck: 1790). Additionally‚ the nose‚ tongue and even the earlobes can be affected (Merck: 1790) (Cooke: 293). If the condition is deemed primary‚ it is known as Raynaud’s disease‚ or primary Raynaud’s phenomenon‚ and is inherently idiopathic (Merck: 1790) (Cooke: 294). On the other hand‚ if the condition is secondary to another disease‚ it is termed Raynaud’s phenomenon
Premium Sympathetic nervous system Blood Autonomic nervous system
Vioxx Decisions – Were They Ethical? In the late 1990s‚ a pharmaceutical company called Merck was a leader in this industry. The pharmaceutical industry required millions of dollars and great amounts of time to be invested in research and development. From 1995 to 2001‚ Merck was successful in releasing 13 major drugs into the market. One of these drugs was one that would treat rheumatoid arthritis. The drug‚ Vioxx‚ acquired the approval of the Food and Drug Administration (FDA) in May 2009 (Cavusgil
Premium Pharmacology Myocardial infarction Pharmaceutical drug
Merck & Company‚ Inc: The Recall of Vioxx Introduction Geroge W. Merck stated once stated‚ “We try never to forget that medicine is for the people. It is not for the profits. The profits follow. Initially‚ Vioxx was the blockbuster drug that Merck needed due to the upcoming Zocor patent cliff in 2006. With an estimated 27‚785 heart attacks and sudden cardiac deaths that could have been avoided if Celebrex had been used instead of Vioxx‚ Merck faces the possibility of not only having to pay
Premium Pharmaceutical drug Osteoarthritis Pharmacology